Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Yesafili, received marketing authorization approval from the European Commission for the European Union
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Subscribe To Our Newsletter & Stay Updated
